MedKoo Cat#: 574521 | Name: Cycrimine hydrochloride

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Cycrimine hydrochloride is a cholinolytic anti-Parkinson drug which can cause neuromuscular blockades in isolated rat diaphragms.

Chemical Structure

Cycrimine hydrochloride
Cycrimine hydrochloride
CAS#126-02-3 (HCl)

Theoretical Analysis

MedKoo Cat#: 574521

Name: Cycrimine hydrochloride

CAS#: 126-02-3 (HCl)

Chemical Formula: C19H30ClNO

Exact Mass: 323.2016

Molecular Weight: 323.90

Elemental Analysis: C, 70.46; H, 9.34; Cl, 10.94; N, 4.32; O, 4.94

Price and Availability

Size Price Availability Quantity
Bulk Inquiry
Buy Now
Add to Cart
Synonym
Cycrimine hydrochloride, Cycrimine HCl, Compound 8958; NSC 169452; NSC169452; NSC-169452; Pagitane Hydrochloride
IUPAC/Chemical Name
1-Phenyl-1-cyclopentyl-3-piperidino-1-propanol Hydrochloride
InChi Key
WBCWFMFZMRFRLT-UHFFFAOYSA-N
InChi Code
InChI=1S/C19H29NO.ClH/c21-19(18-11-5-6-12-18,17-9-3-1-4-10-17)13-16-20-14-7-2-8-15-20;/h1,3-4,9-10,18,21H,2,5-8,11-16H2;1H
SMILES Code
OC(C1CCCC1)(C2=CC=CC=C2)CCN3CCCCC3.[H]Cl
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 323.90 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Vedasiromoni JR, Ganguly DK. Cycrimine on rat diaphragm. Arch Int Pharmacodyn Ther. 1976 Jan;219(1):64-9. PMID: 1267542. 2: Matejin S, Bukreyeva N, Radosevic D, Sencanski M, Mantlo E, Veljkovic V, Glisic S, Paessler S. In vitro anti-influenza activity of in silico repurposed candidate drug cycrimine. Antivir Ther. 2019;24(8):589-593. doi: 10.3851/IMP3348. PMID: 32108589. 3: KAFER JP, POCH GF. La cicrimina, una nueva droga en el tratamiento de la enfermedad de Parkinson y de los parkinsonismos [Cycrimine, a new drug in the treatment of Parkinson's disease & Parkinsonism]. Prensa Med Argent. 1957 Apr 5;44(14):1071-5. Spanish. PMID: 13477721. 4: Owen JA, Sribney M, Lawson JS, Delva N, Letemendia FJ. Capillary gas chromatography of trihexyphenidyl, procyclidine and cycrimine in biological fluids. J Chromatogr. 1989 Sep 29;494:135-42. doi: 10.1016/s0378-4347(00)82663-8. PMID: 2573609. 5: NEW AND nonofficial remedies: cycrimine hydrochloride. J Am Med Assoc. 1955 Feb 5;157(6):510-1. PMID: 13221464. 6: SIGWALD J, PAYOT J. Action thérapeutique symptomatique du chlorhydrate de cycrimine sur les syndromes parkinsoniens [Symptomatic therapeutic effect of cycrimine HCl in parkinsonian syndromes]. Presse Med (1893). 1955 Mar 12;63(19):375-6. French. PMID: 14371520. 7: RENZI AA, MILCH LJ. Effectiveness of procyclidine hydrochloride (kemadrin) and cycrimine hydrochloride (pagitane) in the prevention of airsickness. J Aviat Med. 1958 Aug;29(8):587-9. PMID: 13575361. 8: Sotriffer CA, Liedl KR, Winger RH, Gamper AM, Kroemer RT, Linthicum DS, Rode BM, Varga JM. Heteroligation of a mouse monoclonal IgE antibody (La2) with small molecules, analysed by computer-aided automated docking. Mol Immunol. 1996 Feb;33(2):129-44. doi: 10.1016/0161-5890(95)00124-7. PMID: 8649435. 9: Winger RH, Liedl KR, Sotriffer CA, Gamper AM, Rode BM, Kroemer RT, Varga JM. Prediction of IgE(Lb4)-ligand complex structures by automated docking. J Mol Recognit. 1996 May-Jun;9(3):239-46. doi: 10.1002/(sici)1099-1352(199605)9:3<239::aid-jmr265>3.0.co;2-f. PMID: 8938597. 10: Occelli E, Fontanella L, Testa E. Analoghi biciclici della piperazina XII (1)-Sintesi di 3,8-diazabiciclo [3,2,1] ottani come potenziali antiparkinsoniani [Bicyclic analogs of piperazine. XII. (1) - Synthesis of 3,8-diazabicyclo/3,2,1/octanes as potential antiparkinson agents]. Farmaco Sci. 1977 Apr;32(4):237-47. Italian. PMID: 862878.